Cost-Effectiveness Analysis of Continuous-Flow Left Ventricular Assist Devices as Destination Therapy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation: Heart Failure

• Publication date

  2012-01-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.111.962951PMID 22052901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Care and Outcomes of Hispanic Patients Admitted With Heart Failure With Preserved or Reduced Ejection Fraction: Findings From Get With The Guidelines–Heart Failure

  2012cited by this paper
• p53 Promotes Cardiac Dysfunction in Diabetic Mellitus Caused by Excessive Mitochondrial Respiration-Mediated Reactive Oxygen Species Generation and Lipid Accumulation

  2012cited by this paper
• Irregular Rhythm Adversely Influences Calcium Handling in Ventricular Myocardium: Implications for the Interaction Between Heart Failure and Atrial Fibrillation

  2012cited by this paper
• Decline in Heart Transplant Wait List Mortality in the United States Following Broader Regional Sharing of Donor Hearts

  2012cited by this paper
• Plasticity of Surface Structures and &bgr;2-Adrenergic Receptor Localization in Failing Ventricular Cardiomyocytes During Recovery From Heart Failure

  2012cited by this paper
• Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy: Systematic Review and Meta-Analysis

  2012cited by this paper
• Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic Dysfunction: The HF-ACTION Predictive Risk Score Model

  2012cited by this paper
• Economic Burden of Heart Failure in the Elderly

  2012cited by this paper
• National Survey of Hospital Strategies to Reduce Heart Failure Readmissions: Findings From the Get With the Guidelines-Heart Failure Registry

  2012cited by this paper
• Habitual Coffee Consumption and Risk of Heart Failure: A Dose-Response Meta-Analysis

  2012cited by this paper
• Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation

  2012cited by this paper
• Temporal Changes in Hospital Costs for Left Ventricular Assist Device

  2011cited by this paper
• Temporal Changes in Hospital Costs for Left Ventricular Assist Device Implantation

  2011cited by this paper
• Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.

  2010cited by this paper
• How to Assess the Value of Medicines?

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial

  2009cited by this paper
• Rehospitalizations among patients in the Medicare fee-for-service program.

  2009cited by this paper
• Rise of the machines--left ventricular assist devices as permanent therapy for advanced heart failure.

  2009cited by this paper
• Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations.

  2009cited by this paper
• Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device

  2009cited by this paper
• Rehospitalizations among patients in the Medicare fee-for-service program.

  2009cited by this paper
• Advanced heart failure treated with continuous-flow left ventricular assist device.

  2009cited by this paper
• The cost of medical management in advanced heart failure during the final two years of life.

  2008cited by this paper
• Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates.

  2007cited by this paper
• Mechanical Circulatory Support Therapy In Advanced Heart Failure

  2007cited by this paper
• Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: A systematic review and economic evaluation

  2007cited by this paper
• Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.

  2006cited by this paper
• Left ventricular assist devices as destination therapy for end-stage heart failure

  2004cited by this paper
• Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure.

  2004cited by this paper
• Cost-effectiveness of left ventricular assist devices

  2003cited by this paper
• Left Ventricular Assist Devices as Permanent Heart Failure Therapy: The Price of Progress

  2003influential reference
• Long-term use of a left ventricular assist device for end-stage heart failure.

  2001influential reference
• The cost of long-term LVAD implantation.

  2001cited by this paper
• Evolving costs of long-term left ventricular assist device implantation.

  1997cited by this paper
• Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

  1996cited by this paper

• The Cost of Medical Management in Advanced Heart Failure: A Latin American Perspective

  2025cites this paper
• Cost-Effectiveness of Left Ventricular Assist Device for Transplant-Ineligible Patients

  2025cites this paper
• Outcomes of Left Ventricular Assist Devices as Destination Therapy: A Systematic Review with Meta-Analysis

  2025influential citation
• Custos do Tratamento Clínico de Pacientes com Insuficiência Cardíaca Avançada na América Latina

  2025cites this paper
• Economic aspects of long‐term left ventricular assist device treatment for chronic heart failure

  2024cites this paper
• The economics of heart failure care.

  2024cites this paper
• Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization‐therapy nonresponders

  2024cites this paper
• Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.

  2024cites this paper
• Design and optimisation of an Intra-Aortic Shrouded rotor axial pump.

  2023cites this paper
• Thrivival: Thriving and Surviving for Left Ventricular Assist Device Patients.

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom

  2022cites this paper
• Intravenous administration of umbilical cord lining stem cells in left ventricular assist device recipient: Rationale and design of the uSTOP LVAD BLEED pilot study

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Cost-effectiveness and system-wide impact of using Hepatitis C-viremic donors for heart transplant.

  2021cites this paper
• A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.

  2021cites this paper
• A varied approach to left ventricular assist device follow-up improves cost-effectiveness

  2021cites this paper
• Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

  2021influential citation
• Quality of economic evaluations of ventricular assist devices: A systematic review

  2020influential citation
• Statistics of heart failure and mechanical circulatory support in 2020

  2020cites this paper
• Psychosocial and Quality of Life Issues in Mechanical Circulatory Support

  2020cites this paper
• Two year adverse outcomes of the magnetic levitated centrifugal continuous flow circulatory pump versus the axial continuous-flow pump for advanced heart failure

  2020cites this paper
• Therapies for Advanced Heart Failure Patients Ineligible for Heart Transplantation: Beyond Pharmacotherapy.

  2020cites this paper
• Clinical Demands and Challenges for Future Mechanical Circulatory Support Technologies

  2020cites this paper
• Avoiding the "set it and forget it mentality": A need to regularly reassess left ventricular assist device patients for optimal support.

  2020cites this paper
• Cost‐effectiveness of using hepatitis C viremic hearts for transplantation into HCV‐negative recipients

  2020cites this paper
• Cost-Effectiveness of Long-Term Left Ventricular Assist Device Support: Is the Extra-Welfarist Model Suitable for Advanced Heart Failure?

  2020cites this paper
• Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device

  2020cites this paper
• Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device

  2020cites this paper
• Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device.

  2020cites this paper
• 2019 EACTS Expert Consensus on long-term mechanical circulatory support

  2019cites this paper
• Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.

  2019cites this paper
• Left ventricular assist devices as destination therapy in stage D heart failure

  2019cites this paper
• Cost‐utility of continuous‐flow ventricular assist devices as bridge to transplant in pediatrics

  2019cites this paper
• Improving Value-Based Care for Left Ventricular Assist Device Therapy: Lowering Costs When Stakes Are High.

  2019cites this paper
• The Effect of Total Cost Information on Consumer Treatment Decisions: An Experimental Survey

  2018cites this paper
• A Systematic Review of Cost-Effectiveness Analyses of Left Ventricular Assist Devices: Issues and Challenges

  2018cites this paper
• Managing the Economic Challenges in the Treatment of Heart Failure.

  2018cites this paper
• Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine

  2018cites this paper
• Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review

  2018cites this paper
• Chapter 24 – Cost-effectiveness

  2018cites this paper
• Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy

  2018cites this paper
• 89 – Ventricular Arrhythmias in Heart Failure

  2018cites this paper
• Renal risk stratification in left ventricular assist device therapy

  2018cites this paper
• Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure

  2018cites this paper
• Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement

  2018cites this paper
• Viscosity Prediction in a Physiologically Controlled Ventricular Assist Device

  2018cites this paper
• Physiotherapy and Rehabilitation Management in Adult LVAD Patients

  2017cites this paper
• The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy.

  2017cites this paper
• Cost‐effectiveness of left ventricular assist devices for patients with end‐stage heart failure: analysis of the French hospital discharge database

  2017influential citation
• Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation.

  2017cites this paper
• Cost‐Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System

  2017cites this paper
• Hidden Bias in Cost-Analysis Research: What Is the Prevalence of Under-Reporting Cost Perspective in the General Surgical Literature?

  2017cites this paper
• Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.

  2017cites this paper
• Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.

  2017cites this paper
• Mind the Gap: Current Challenges and Future State of Heart Failure Care.

  2017cites this paper
• Advanced Heart Failure and Left Ventricular Assist Devices-Are we there yet ?-A Review of the Literature

  2017cites this paper
• Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs

  2017cites this paper
• Health-Economic Aspects of MCS Therapy

  2017cites this paper
• Frailty and Advanced Heart Failure in Older Adults

  2017cites this paper
• Left Ventricular Assist Devices for Lifelong Support.

  2017cites this paper
• An updated review of cardiac devices in heart failure

  2017cites this paper
• Cost-effectiveness analysis in cardiac surgery: A review of its concepts and methodologies.

  2017cites this paper
• Advances in Heart Failure Frailty and the Selection of Patients for Destination Therapy Left Ventricular Assist Device

  2017cites this paper
• The In-Hospital Cost of Ventricular Assist Device Therapy: Implications for Patient Selection

  2016cites this paper
• Current Status of the Left Ventricular Assist Device as a Destination Therapy

  2016cites this paper
• Left ventricular assist devices in the treatment of end-stage heart failure

  2016cites this paper
• Asistencia mecánica circulatoria como puente al trasplante

  2016cites this paper
• A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support.

  2016cites this paper
• Pathophysiology of Heart Failure and an Overview of Therapies

  2016cites this paper
• Patient Selection for Long-Term Mechanical Circulatory Support: Is It Ever too Early for the NYHA Class III Patient?

  2016cites this paper
• Future Prospects for the Total Artificial Heart

  2016cites this paper
• Left ventricular assist device: a bridge to transplant or destination therapy?

  2016cites this paper
• Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes

  2016cites this paper
• Left ventricular assist devices-current state and perspectives.

  2016cites this paper
• Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.

  2016cites this paper
• Feasibility Study of Particulate Extracellular Matrix (P-ECM) and Left Ventricular Assist Device (HVAD) Therapy in Chronic Ischemic Heart Failure Bovine Model

  2015cites this paper
• A Review of Long-TermMechanical Circulatory Support as Destination Therapy: Evolving Paradigms for Treatment of Advanced Heart Failure

  2015cites this paper
• Epidemiology of Cardiac Surgery and the Cardiac Surgical Patient

  2015cites this paper
• Extracorporeal Membrane Oxygenation for the Support of Adults With Acute Myocarditis

  2015cites this paper
• Heart transplantation versus continuous-flow left ventricular assist device: comprehensive cost at 1 year.

  2015cites this paper
• Cardiac Intensive Care

  2015cites this paper
• Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy.

  2015cites this paper
• Mechanical circulatory support for the failing heart – progress, pitfalls and promises.

  2015cites this paper
• Palliative Care and Hospice in Patients with Advanced Cardiovascular Disease

  2015cites this paper
• The Price of a Helping Hand: Modeling the Outcomes and Costs of Bystander CPR

  2015cites this paper
• Left Ventricular Assist Devices: The Adolescence of a Disruptive Technology.

  2015cites this paper
• Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.

  2015cites this paper
• Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.

  2015cites this paper
• Temporary extracorporeal left ventricular assist device support for implantable left ventricular assist device replacement cases.

  2014cites this paper
• A contemporary review of mechanical circulatory support.

  2014cites this paper
• The changing landscape of advanced heart failure therapeutics.

  2014cites this paper
• Health economics of percutaneous hemodynamic support in the treatment of high-risk cardiac patients: a systematic appraisal of the literature

  2014cites this paper
• An Old Assist Device for a Potential New Indication in Refractory Heart Failure

  2014cites this paper
• Transplant Versus VAD: Evolving and Future Perspectives

  2014cites this paper
• Insuficiencia cardíaca: diagnóstico y tratamiento Un análisis pormenorizado de los criterios de diagnóstico en cada etapa evolutiva con sus alternativas terapéuticas actualizadas .

  2014cites this paper
• Current Options and Practices in Long-Term Ventricular Assist Devices

  2014cites this paper
• Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach

  2014cites this paper